Jump to navigation
STEM CELLS | STEM CELLS Translational Medicine
A new study uncovers the mechanisms which mediate the lower osteogenic potential of mesenchymal stem cells in patients suffering from multiple myeloma.
Researchers demonstrate how bone marrow derived mesenchymal stem cells reduce chronic neuropathic pain/neuronal hyperexcitability in patients suffering from spinal cord injury
Researchers show that repeated injections of MSCs are safe and feasible in ALS patients
Researchers delineate the mechanisms behind the pro-angiogenic role of stem cell-derived exosomes highlighting a role for the Wnt/β-Catenin pathway
Review of “Pre-exposure of Human Adipose Mesenchymal Stem Cells to Soluble Factors Enhances their Homing to Brain Cancer” from Stem Cells TM by Stuart P. Atkinson
Review of “Engineered Mesenchymal Stem Cells with Enhanced Tropism and Paracrine Secretion of Cytokines and Growth Factors to Treat TBI” from Stem Cells by Stuart P. Atkinson
Researchers discover that ageing alters mesenchymal stem cell population dynamics, leading to an accumulation of non-functional cells
MSC-laden cell injections into lumbar discs mediate a significant reduction in back pain, promoting this minimally invasive stem cell strategy
A pretty “sweet” Stem Cells article has been hitting the news this week.
Mesenchymal stem cells found to be effective in treating models of atherosclerosis in vitro and in vivo
The Stem Cells Portal is a shared platform for the STEM CELLS and STEM CELLS Translational Medicine sister journals, providing up-to-the-minute coverage of the latest research from bench science and developments to clinical applications.
STEM CELLS Translational Medicine is the official journal partner of
STEM CELLS Translational Medicine is the official journal of
STEM CELLS is the official journal of
Copyright © 2017